FTSE 100 pharmaceutical giant GSK (LSE: GSK) has seen its shares rise 25% from their 12-month 11 July low. But a sharply rising price does not mean there is no value left in a stock. It could simply be that the market is playing catch-up with the fair value of a company. And it could well be that the ...
motleyfooluklse:gsk
“Our favourite holding period is forever.” So says the great Warren Buffett, and who are we to argue! While the practicalities of buying and owning shares in a quality company without ever selling comes with some caveats, it remains a good rule of thumb to aim for. Here are the stocks that five of our ...
motleyfoolukusx:aapllse:gsklse:dgeusx:cahlse:lseg
While the current recession in Britain isn’t expected to last much more than a few years in total, it’s still worth considering which stocks might be resiliant to one in the future. Often in similar scenarios, investors turn to stalwarts — many of which reside in the FTSE 100 — for safety. GSK What it ...
motleyfooluklse:gsklse:lloylse:ulvr
Building a passive income stream from dividend paying stocks is a tried and tested method many seasoned investors undertake. The general rule of thumb is that diversification is a must to ensure maximum returns, as well as protection for my portfolio. However, let’s say for the purposes of this article ...
motleyfooluklse:gsklse:ng
I’m building a portfolio of FTSE 100 dividend income stocks to top up my State Pension when I finally retire. That day is still more than a decade away, but if I was calling it quits tomorrow, I’d buy these three sares for long-term dividends and growth. I recently bought a stake in pharmaceutical company ...
motleyfooluklse:gsklse:hsba
Investor demand for FTSE 100 shares is surging as confidence returns to the UK stock market. London’s premier share index has moved above 8,000 points for the first time since early 2023 on Tuesday (2 April). It could be on course to print record closing highs later today. The fragile economic and political ...
motleyfooluklse:gsklse:abf
The FTSE 100 has gone on a tear just as the deadline for using this year’s Stocks and Shares ISA allowance looms. So is there still good value out there? Happily, I think there is. As with any rally, some shares refused to participate. That applies to one of my favourite portfolio holdings, wealth manager ...
motleyfooluklse:gsklse:rtolse:mng
With a forward-looking yield near 4%, FTSE 100 dividend stock GSK (LSE: GSK) looks tempting for shareholder income. But the biopharmaceutical company has its sights firmly set on rebooting its growth mojo. And there’s mounting evidence the business may be succeeding in that ambition. So my assumption ...
motleyfooluklse:gsk
